Position in JNJ
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$6,355,853
+$370,985 QoQ
Shares Held
25,026
+2.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.48%
of 13F equity value
Holder Rank
#1,438
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fragasso Financial Advisors Inc holds $24,423,418 across 9 Drug Manufacturers - General names. JNJ ranks #1 (26.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
25,026 | $6,355,853 | |
| 2 | LLY |
ELI LILLY & Co
|
4,609 | $5,528,173 | |
| 3 | ABBV |
AbbVie Inc.
|
21,001 | $5,284,691 | |
| 4 | AMGN |
Amgen Inc
|
11,714 | $4,241,873 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,421 | $1,596,098 | |
| 6 | PFE |
Pfizer Inc
|
22,006 | $529,904 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,989 | $377,630 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,605 | $265,340 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,355,853 | 25,026 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $5,984,868 | 24,484 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $5,407,189 | 26,128 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $4,931,430 | 26,596 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $4,223,232 | 27,648 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $4,616,653 | 27,838 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $1,922,722 | 13,295 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $2,176,627 | 13,431 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $2,108,211 | 14,424 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $2,309,890 | 14,602 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $2,291,225 | 14,618 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $2,241,709 | 14,393 | Shares | Sole | 2023-12-06 | |
| 2023-06-30 | $2,385,143 | 14,410 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $2,158,840 | 13,928 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $2,453,138 | 13,887 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $2,281,812 | 13,968 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $2,449,638 | 13,800 | Shares | Sole | 2022-08-30 | |
| 2022-03-31 | $2,476,257 | 13,972 | Shares | Sole | 2022-04-06 | |
| 2021-12-31 | $2,340,066 | 13,679 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $2,109,513 | 13,062 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $2,138,160 | 12,979 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $2,118,964 | 12,893 | Shares | Sole | 2021-05-27 | |
| 2020-12-31 | $2,010,214 | 12,773 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $1,782,391 | 11,972 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $4,677,213 | 33,259 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $4,291,098 | 32,724 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||